LABP - Landos Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Landos Biopharma's activity chart (see below) currently has 17 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 12.5% of the time, taking 129.5 days on average.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 01-Mar-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Oct-2021

$20.42

$500

2 years 7 months 21 days ago
(01-Apr-2024)

0/2 (0%)

$-1.18 (-5.46%)

Hold Since 06-Jan-2023

$1

$14

3 years 10 months 16 days ago
(06-Jan-2023)

1/4 (25%)

$-3.05 (-75.31%)

713

Hold Since 12-Aug-2022

4 years 11 days ago
(11-Nov-2022)

0/2 (0%)

$53.4 (50.09%)

Buy Since 01-Mar-2021

$60

$90

4 years 3 months 10 days ago
(12-Aug-2022)

0/3 (0%)

$49.4 (466.04%)

Hold Since 01-Mar-2021

$70

$170

4 years 10 months 19 days ago
(03-Jan-2022)

0/2 (0%)

$17.8 (34.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LABP (Landos Biopharma) average time for price targets to be met?

On average it took 130 days for the stock forecasts to be reached, with an average price target met ratio of 12.5%.

Which analyst most recently updated their price target on LABP (Landos Biopharma)?

Raghuram Selvaraju

Which analyst has the lowest performance score on LABP (Landos Biopharma) with a proven track record?

ROBIN GARNER

Which analyst has the most public recommendations on LABP (Landos Biopharma)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 12 price targets and 12 ratings on LABP

Which analyst is the currently most bullish on LABP (Landos Biopharma)?

Jessica Fye with the highest potential upside of $47.07

Which analyst is the currently most reserved on LABP (Landos Biopharma)?

Chris Howerton with the lowest potential downside of -$21.93
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?